Global AI-based Medical Diagnostic Tools Market Size study, by Component (Software, Services, Hardware), by Application (Radiology, Cardiology, Neurology, Oncology, Others), by End-user (Hospitals, Diagnostic Laboratories, Others), and Regional Forecasts

Global AI-based Medical Diagnostic Tools Market Size study, by Component (Software, Services, Hardware), by Application (Radiology, Cardiology, Neurology, Oncology, Others), by End-user (Hospitals, Diagnostic Laboratories, Others), and Regional Forecasts 2022-2032

Global AI-based Medical Diagnostic Tools Market is valued approximately at USD 1.3 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 20.8% over the forecast period 2024-2034. AI-based Medical Diagnostic Tools tools leverage advanced algorithms and machine learning techniques to analyze medical data, such as imaging scans, lab results, and patient histories, to provide accurate and timely diagnoses. AI-powered systems in diagnostics provide precise and efficient diagnoses, enabling healthcare personnel to devise adequate and timely treatment plans. The AI-based medical diagnostic tools market is a rapidly growing sector that focuses on utilizing artificial intelligence (AI) to enhance the accuracy, efficiency, and effectiveness of medical diagnoses. These tools employ sophisticated machine learning algorithms and data analytics to process and interpret vast amounts of medical data, including imaging scans (such as X-rays, MRIs, and CT scans), pathology slides, genetic information, and electronic health records (EHRs). By analyzing patterns and anomalies in the data, AI-based diagnostic tools can assist healthcare professionals in identifying diseases and conditions more quickly and accurately than traditional methods.

Companies operating in the AI-based medical diagnostic tools market are focusing on developing non-invasive, AI-based diagnostic tools that facilitate precise brain tumor diagnosis. Additionally, they are exploring the incorporation of AI-based remote medical devices for elderly nursing care services. Such AI-based clinical insights modules help doctors diagnose ailments even from a distance. The healthcare vertical is increasingly integrating AI-powered solutions in medical diagnostics to achieve higher clinical and operational outcomes, driven by the rising incidence of chronic diseases, which accelerates the demand for innovative, automated processes. The increase in the number of investors funding AI start-ups, particularly for revolutionizing medical diagnostics, is significantly contributing to the growth of the AI-based medical diagnostic tools market. However, data privacy concerns, high costs, lack of standardized protocols are hampering the market growth over the forecast period 2024-2032

The key regions considered for the Global AI-based Medical Diagnostic Tools Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. In 2023, North America dominated the market due to the rising incidence of cancer in the U.S. and the proactive implementation of strategic initiatives by market players. For instance, Roche launched three AI-based, deep learning image analysis Research Use Only (RUO) algorithms for breast cancer in December 2021. The Asia Pacific region is expected to grow steadily from 2024 to 2034, driven by a favorable regulatory environment, foreign investments, and government initiatives promoting awareness and timely treatment of diseases.

Major market players included in this report are:

Microsoft Corporation

Nvidia Corporation

Merative L.P.

Alphabet, Inc

Intel Corporation

Siemens Healthineers

GE HealthCare

Advanced Micro Devices, Inc.

Koninklijke Philips N.V.

InformAI

Zebra Medical Vision Ltd.

Aidoc Medical Ltd.

Viz.ai, Inc.

Arterys Inc.

Tempus Labs, Inc.

The detailed segments and sub-segment of the market are explained below:

By Component:

Software

Services

Hardware

Memory

Others

By Application:

Radiology

Cardiology

Neurology

Oncology

Others

By End-user:

Hospitals

Diagnostic Laboratories

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Middle East & Africa

Saudi Arabia

South Africa

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.